EDWARDS LIFESCIENCES CORPORATION Funds and ETFs Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.72 USD | -0.80% |
|
+1.72% | +13.73% |
ETFs positioned on Edwards Lifesciences Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.02% | 0 M€ | +0.32% | - | |
| 0.01% | 0 M€ | +3.95% | - | |
| 0.01% | 0 M€ | -0.73% | - | |
| 0.01% | 0 M€ | +3.63% | - | |
| 5.02% | 0 M€ | +6.50% | - |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
86.72
USD
Average target price
95.27
USD
Spread / Average Target
+9.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.73% | 52.26B | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| -0.04% | 63.19B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B | |
| +24.30% | 31.41B |
- Stock Market
- Equities
- EW Stock
- Funds and ETFs Edwards Lifesciences Corporation